Results 141 to 150 of about 10,726 (197)

Physiologically Based Pharmacokinetic Model of Brigatinib in Healthy Volunteers and Patients With Cancer. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
Xu Y   +6 more
europepmc   +1 more source

Safety, tolerability, pharmacokinetics, and pharmacodynamics of zapnometinib: results from a phase I clinical study. [PDF]

open access: yesFront Pharmacol
Stenglein S   +7 more
europepmc   +1 more source

Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer's disease therapy. [PDF]

open access: yesFront Pharmacol
Li Z   +15 more
europepmc   +1 more source

Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations. [PDF]

open access: yesJ Pharmacokinet Pharmacodyn
Choules MP   +5 more
europepmc   +1 more source

Improving hepatic metabolic function with 3D iPSC-derived human hepatocytes. [PDF]

open access: yesCell Biol Toxicol
Pozo Garcia V   +7 more
europepmc   +1 more source

Assessing ADME gene coverage: An observational study on chloroquine therapy for COVID-19. [PDF]

open access: yesMedicine (Baltimore)
Zaid N   +9 more
europepmc   +1 more source

Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester. [PDF]

open access: yesEur J Clin Pharmacol
Mian P   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy